tiprankstipranks
Advertisement
Advertisement

RARE Stock Latest News

Is RARE a Buy, Before Earnings?
Pre-EarningsIs RARE a Buy, Before Earnings?
1d ago
RARE
Ultragenyx Pharmaceutical, Inc. (RARE) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Ultragenyx Pharmaceutical, Inc. (RARE) Q2 Earnings Cheat Sheet
6d ago
RARE
Ultragenyx price target raised to $30 from $26 at Wedbush
PremiumThe Fly
Ultragenyx price target raised to $30 from $26 at Wedbush
21d ago
RARE
ASE, ProQR, AbSci, Ultragenyx, YPF: Insider Turmoil
PremiumWeekend Updates
ASE, ProQR, AbSci, Ultragenyx, YPF: Insider Turmoil
23d ago
ASX
YPF
Ultragenyx price target raised to $40 from $35 at RBC Capital
PremiumThe Fly
Ultragenyx price target raised to $40 from $35 at RBC Capital
27d ago
RARE
Ultragenyx: Favorable Risk-Reward Ahead of GTX-102 ASPIRE Readout, Analyst Reiterates Buy and $72 Price Target
PremiumRatingsUltragenyx: Favorable Risk-Reward Ahead of GTX-102 ASPIRE Readout, Analyst Reiterates Buy and $72 Price Target
27d ago
RARE
Acting FDA head vows to block political interference, Endpoint News says
Premium
The Fly
Acting FDA head vows to block political interference, Endpoint News says
2M ago
AZN
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
Premium
The Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
2M ago
AZN
BMY
Ultragenyx price target raised to $96 from $84 at Cantor Fitzgerald
PremiumThe Fly
Ultragenyx price target raised to $96 from $84 at Cantor Fitzgerald
2M ago
RARE
Ultragenyx Earnings Call Balances Growth and Cash Burn
PremiumCompany Announcements
Ultragenyx Earnings Call Balances Growth and Cash Burn
3M ago
RARE
Ultragenyx Shareholders Approve Incentive Plan, Elect Directors
PremiumCompany Announcements
Ultragenyx Shareholders Approve Incentive Plan, Elect Directors
3M ago
8K
RARE
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
PremiumThe Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
3M ago
AZN
BMY
Trump approves plan to fire FDA head Marty Makary, CBS reports
PremiumThe FlyTrump approves plan to fire FDA head Marty Makary, CBS reports
3M ago
DYN
RNA
Ultragenyx price target lowered to $33 from $34 at Evercore ISI
Premium
The Fly
Ultragenyx price target lowered to $33 from $34 at Evercore ISI
3M ago
RARE
Ultragenyx price target lowered to $26 from $27 at Wedbush
Premium
The Fly
Ultragenyx price target lowered to $26 from $27 at Wedbush
3M ago
RARE
Ultragenyx price target lowered to $43 from $52 at Guggenheim
PremiumThe Fly
Ultragenyx price target lowered to $43 from $52 at Guggenheim
3M ago
RARE
Ultragenyx Earnings Call: Growth, Gene Therapy and Risk
PremiumCompany Announcements
Ultragenyx Earnings Call: Growth, Gene Therapy and Risk
3M ago
RARE
Ultragenyx price target lowered to $43 from $44 at Barclays
PremiumThe Fly
Ultragenyx price target lowered to $43 from $44 at Barclays
3M ago
RARE
Is RARE a Buy, Before Earnings?
PremiumPre-Earnings
Is RARE a Buy, Before Earnings?
3M ago
RARE
Ultragenyx price target raised to $67 from $50 at Morgan Stanley
PremiumThe FlyUltragenyx price target raised to $67 from $50 at Morgan Stanley
4M ago
RARE
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
Premium
The Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
4M ago
DYN
RNA
Ultragenyx BLA for UX111 Accepted for FDA Review
Premium
Company Announcements
Ultragenyx BLA for UX111 Accepted for FDA Review
4M ago
8K
RARE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >